Quick Answer
NOVAVAX INC reported Earnings Per Share Diluted of $2.58 per share for the year ending 2025.
- NOVAVAX INC showed an increase of +309.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $0.30 (loss) per share | Q3 2020: $3.21 (loss) per share | Q1 2021: $3.05 (loss) per share | Q2 2021: $4.75 (loss) per share | Q3 2021: $4.31 (loss) per share | Q1 2022: $2.56 per share | Q2 2022: $6.53 (loss) per share | Q3 2022: $2.15 (loss) per share | Q1 2023: $3.41 (loss) per share | Q2 2023: $0.58 per share | Q3 2023: $1.26 (loss) per share | Q1 2024: $1.05 (loss) per share | Q2 2024: $0.99 per share | Q3 2024: $0.76 (loss) per share | Q1 2025: $2.93 per share | Q2 2025: $0.62 per share | Q3 2025: $1.25 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), NOVAVAX INC's Earnings Per Share Diluted has grown by 146.8%.
- Historical annual values: Fiscal year 2025: $2.58 per share | Fiscal year 2024: $1.23 (loss) per share | Fiscal year 2023: $5.41 (loss) per share | Fiscal year 2022: $8.42 (loss) per share | Fiscal year 2021: $23.44 (loss) per share | Fiscal year 2020: $7.27 (loss) per share | Fiscal year 2019: $5.51 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: